Drug Watch

Latest News

Addressing Ongoing Benzoyl Peroxide and Benzene Updates at AAD 2025
Addressing Ongoing Benzoyl Peroxide and Benzene Updates at AAD 2025

March 11th 2025

Christopher Bunick, MD, PhD, discussed how to interpret recent benzene research as clinicians await regulatory guidance for benzoyl peroxide.

Expert Insights Into L'Oréal’s Voluntary Recall of Benzoyl Peroxide Products
Expert Insights Into L'Oréal’s Voluntary Recall of Benzoyl Peroxide Products

March 10th 2025

L'Oréal Issues Voluntary Recall of Benzoyl Peroxide Products Over Benzene Concerns
L'Oréal Issues Voluntary Recall of Benzoyl Peroxide Products Over Benzene Concerns

March 10th 2025

Medicus Reports Promising Interim Results for Non-Invasive BCC Treatment
Medicus Reports Promising Interim Results for Non-Invasive BCC Treatment

March 10th 2025

Late-Breaking Data: Phase 3 Updates on Ruxolitinib Cream for Prurigo Nodularis
Late-Breaking Data: Phase 3 Updates on Ruxolitinib Cream for Prurigo Nodularis

March 8th 2025

More News

Arm with psoriasis

Patient enrollment complete for tapinarof long-term safety study for psoriasis

Morgan Petronelli
June 12th 2020

Dermavant announces the enrollment completion for their long-term safety study investigating tapinarof in adults with plaque psoriasis as a part of the PSOARING 1 and PSOARING 2 phase 3 program.

<1
...
89101112
© 2025 MJH Life Sciences

All rights reserved.